Exploration of the biological behavior and fate of nanoparticles,
as affected by the nanomaterial–biology (nano–bio) interaction,
has become progressively critical for guiding the rational design
and optimization of nanomedicines to minimize adverse effects, support
clinical translation, and aid in evaluation by regulatory agencies.
Because of the complexity of the biological environment and the dynamic
variations in the bioactivity of nanomedicines, in-situ, label-free analysis of the transport and transformation of nanomedicines
has remained a challenge. Recent improvements in optics, detectors,
and light sources have allowed the expansion of advanced light source
(ALS) analytical technologies to dig into the underexplored behavior
and fate of nanomedicines in vivo. It is increasingly
important to further develop ALS-based analytical technologies with
higher spatial and temporal resolution, multimodal data fusion, and
intelligent prediction abilities to fully unlock the potential of
nanomedicines. In this Outlook, we focus on several selected ALS analytical
technologies, including imaging and spectroscopy, and provide an overview
of the emerging opportunities for their applications in the exploration
of the biological behavior and fate of nanomedicines. We also discuss
the challenges and limitations faced by current approaches and tools
and the expectations for the future development of advanced light
sources and technologies. Improved ALS imaging and spectroscopy techniques
will accelerate a profound understanding of the biological behavior
of new nanomedicines. Such advancements are expected to inspire new
insights into nanomedicine research and promote the development of
ALS capabilities and methods more suitable for nanomedicine evaluation
with the goal of clinical translation.